Savara Appoints Braden Parker as Chief Commercial Officer, Effective Immediately
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...
FiercePharma2 天
Savara, eyeing rare disease drug submission next year, nabs Orchard's commercial lead to ...
Savara says it will in the first of half next year seek an FDA license to treat autoimmune pulmonary alveolar proteinosis ...
Savara Announces New Employment Inducement Grant
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced ...
Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving ...
Shares of Summit Therapeutics Inc. SMMT rose sharply in today's pre-market trading after the company said Ivonescimab Monotherapy reduced the risk of disease progression or death by 49% compared to ...